Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joseph Liao
Mp65-15 Humanized Anti-Cd47 Antibody (Hu-5f9-G4) for Metastatic Bladder Cancer Is Superior to Conventional Chemotherapy With Cisplatin and Gemcitabine in a Murine Bladder Cancer Model.
Journal of Urology
Urology
Related publications
Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer
Oncologist
Cancer Research
Medicine
Oncology
1,25D3 Enhances Antitumor Activity of Gemcitabine and Cisplatin in Human Bladder Cancer Models
Cancer
Cancer Research
Oncology
Complete Response to Anti-Pd-L1 Antibody in a Metastatic Bladder Cancer Associated With Novel MSH4 Mutation and Microsatellite Instability
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
CD47-targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer
Clinical Cancer Research
Cancer Research
Oncology
Role of Combination Chemotherapy With 5-Fluorouracil, Cisplatin and Paclitaxel for Advanced Gall Bladder Cancer
Journal of Cancer Therapy
Intra-Arterial Chemotherapy for Bladder Preservation in Patients With Locally Advanced Bladder Cancer
Japanese Journal of Urology
Urology
Antibody-Drug Conjugates in Bladder Cancer
Bladder Cancer
Oncology
Urology
Immune Checkpoint Inhibitors for Metastatic Bladder Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Docetaxel as Second Line After Failure of Gemcitabine/Cisplatin Regimen in Advanced and/or Metastatic Urinary Bladder Cancer Patients in Egypt
Research in Oncology